Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of atropine sulfate eye drops for slowing myopia progression in children
CTR20200085Phase 3Completed
- Sponsor
- Xingqi Eye Medicine
- Start
- Aug 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in myopia, sponsored by Xingqi Eye Medicine. Started Aug 2020; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20200085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200085.